Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03870126 · ClinicalTrials.gov registry record · NA
Dose Effect of a Plant Extract on Fatigue
A NA study of Physical Performance and Mental Energy, sponsored by PepsiCo Global R&D.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT03870126: Completed NA study of Physical Performance and Mental Energy, sponsored by PepsiCo Global R&D.
NCT03870126 is a NA study of Physical Performance and Mental Energy that has completed, run by PepsiCo Global R&D. The registered enrollment target is 28 participants, below the 3,605-participant average among 6 other Physical Performance trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03870126, a NA study of Physical Performance and Mental Energy, has completed, sponsored by PepsiCo Global R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
Test the short-term effects of the acute consumption of two separate beverages containing different concentrations of polyphenols, a beverage containing 75 mg of caffeine and a flavored placebo beverage on mental energy and physical performance
Primary Outcome
Changes in subjective measures of mental alertness and mental fatigue through computer administered cognitive test battery domains of short-term memory, attention and mood. Tasks are word presentation, word recognition, picture presentation, picture recognition, Cognitive Demand Battery (CDB) serial 3 and serial 7 subtraction, and Bakan task/Rapid Visual Information Processing (RVIP). Performance measures: % correct, % errors and response time in milliseconds.
Conditions Studied
Interventions
- OTHER Flavored beverage
Study Locations (1)
Georgia
- University of Georgia - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2019-01-29 |
| Est. Completion | 2019-12-06 |
| Phase | NA |
What the finished NCT03870126 record still lists
NCT03870126 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 3,605-participant average among 6 other Physical Performance trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Physical Performance appearing as the primary indexed condition, and to 1 intervention - of which Flavored beverage is the first listed.
NCT03870126 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT03870126 about?
NCT03870126 is a clinical study titled "Dose Effect of a Plant Extract on Fatigue". Test the short-term effects of the acute consumption of two separate beverages containing different concentrations of polyphenols, a beverage containing 75 mg of caffeine and a flavored placebo beverage on mental energy and physical performance
What is the current status of trial NCT03870126?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2019-01-29. Estimated completion is 2019-12-06.
What conditions does trial NCT03870126 study?
This clinical trial studies the following conditions: Physical Performance, Mental Energy.
What interventions are being tested in trial NCT03870126?
The interventions under investigation include: Flavored beverage (OTHER).
Who is sponsoring clinical trial NCT03870126?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03870126 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Physical Performance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
COcoa Supplement and Multivitamin Outcomes Study: Effects on Falls and Physical Performance
ACTIVE NOT RECRUITING · NA
-
The Acute Effects of Liquid IV's Pre-Workout Supplement on Muscle Endurance & Strength, Energy, and Cognition
COMPLETED · NA
-
Protein Ingestion Timing on Body Composition and Biochemical Markers in Resistance-trained Males
COMPLETED · NA
-
Characteristics of Performance in Collegiate Cheerleaders and Dancers
RECRUITING
-
Body Composition and Lifestyle Factors in ROTC
RECRUITING
-
Impact of Erythropoietin on Hematological Adaptations and Physical Performance
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI